The review of the light parameters and mechanisms of Photobiomodulation on melanoma cells

Photodermatol Photoimmunol Photomed. 2022 Jan;38(1):3-11. doi: 10.1111/phpp.12715. Epub 2021 Jul 7.

Abstract

Photobiomodulation (PBM) uses low-intensity visible or near-infrared light to produce beneficial effects on cells or tissues, such as brain therapy, wound healing. Still there is no consistent recommendation on the parameters (dose, light mode, wavelength, irradiance) and protocols (repetition, treatment duration) for its clinical application. Herein, we summarize the current PBM parameters for the treatment of melanoma, and we also discuss the potential photoreceptors and downstream signaling mechanisms in the PBM treatment of melanoma cells. It is hypothesized that PBM may inhibit the melanoma cells by activating mitochondria, OPNs, and other receptors. Regardless of the underlying mechanisms, PBM has been shown to be beneficial in treating melanoma. Through further in-depth studies of the underlying potential mechanisms, it can strengthen the applications of PBM for the therapy of melanoma.

Keywords: melanoma; mitochondria; opsins; photobiomodulation.

Publication types

  • Review

MeSH terms

  • Humans
  • Infrared Rays
  • Low-Level Light Therapy*
  • Melanoma* / radiotherapy
  • Signal Transduction
  • Wound Healing